SETD2 and metabolic dysfunction-associated steatotic liver disease: In the context of NAFLD, the reduction of hepatic sinusoidal perfusion may lead to an increase in the release of various angiogenic inducing factors such as HGF, HIF - 1, VEGF, thereby inducing angiogenesis and further promoting tumor growth (29, 30).